4120.TWO Orient Europharma Co Ltd

Healthcare Pharmaceuticals Taiwan OTC Exchange
42.25 TWD
Close of Nov 6, 2026
39.05 49.60
Market cap
TWD 3.67B
P/E
-
P/B
0.71x
ROE
-8.0%
Dividend yield
2.76%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 4120.TWO undervalued?

Graham number

The Graham number of Orient Europharma Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Orient Europharma Co Ltd fundamental analysis

No fundamental analysis for Orient Europharma Co Ltd yet.

Orient Europharma Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Orient Europharma Co Ltd

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include weight management, andrology, cardiovascular, respiratory, neurology, cardiovascular, metabolism, obstetrics and gynecology, antibiotic, immunology, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk under the Karihome brand name; and healthcare supplements for liquid nutrition, regular blood lipids,…

Full company profile